Edward M. Kaye

2021 - Stoke Therapeutics

In 2021, Edward M. Kaye earned a total compensation of $8.5M as Chief Executive Officer at Stoke Therapeutics.

Compensation breakdown

Bonus$15,612
Non-Equity Incentive Plan$343,458
Option Awards$7,604,990
Salary$567,698
Other$11,600
Total$8,543,358

Kaye received $7.6M in option awards, accounting for 89% of the total pay in 2021.

Kaye also received $15.6K in bonus, $343.5K in non-equity incentive plan, $567.7K in salary and $11.6K in other compensation.

Rankings

In 2021, Edward M. Kaye's compensation ranked 1,320th out of 12,415 executives tracked by ExecPay. In other words, Kaye earned more than 89.4% of executives.

ClassificationRankingPercentile
All
1,320
out of 12,415
89th
Division
Manufacturing
471
out of 5,505
91st
Major group
Chemicals And Allied Products
171
out of 2,375
93rd
Industry group
Drugs
143
out of 2,096
93rd
Industry
Pharmaceutical Preparations
94
out of 1,546
94th
Source: SEC filing on April 27, 2023.

Kaye's colleagues

We found two more compensation records of executives who worked with Edward M. Kaye at Stoke Therapeutics in 2021.

2021

Barry Ticho

Stoke Therapeutics

Chief Medical Officer

2021

Stephen Tulipano

Stoke Therapeutics

Chief Financial Officer

News

In-depth

You may also like